bismuth subsalicylate 262 MG Chewable Tablet [Bismarex]
RxNorm concept 211149, branded drug (sbd). Prescribable name: Bisma-Rex 262 MG Chewable Tablet.
- RxCUI
- 211149
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/211149 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- bismuth subsalicylate 262 MG (SCDC, consists of)
- bismuth subsalicylate 262 MG [Bismarex] (SBDC, consists of)
- Chewable Tablet (DF, has dose form)
- Bismarex (BN, has ingredient)
- bismuth subsalicylate 262 MG Chewable Tablet (SCD, tradename of)
Linked data
NDCs
- 00122078166
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 211149 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/211149 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 211149. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.